The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma

NCT02414165 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

403

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Glioblastoma Multiforme
Anaplastic Astrocytoma

Interventions

BIOLOGICAL: Toca 511
DRUG: Toca FC
DRUG: Lomustine
DRUG: Temozolomide
BIOLOGICAL: Bevacizumab

Sponsor

Tocagen Inc.